COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 2 for:    GLS-5300
Previous Study | Return to List | Next Study

Evaluate the Safety, Tolerability and Immunogenicity Study of GLS-5300 in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03721718
Recruitment Status : Completed
First Posted : October 26, 2018
Last Update Posted : May 27, 2020
Inovio Pharmaceuticals
International Vaccine Institute
Information provided by (Responsible Party):
GeneOne Life Science, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 30, 2019
Actual Study Completion Date : April 22, 2020